Publication | Closed Access

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

Antitumor ActivityMedicineImmunologyPharmacologyImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentOncologyCancer ResearchTumor BiologyDrug DiscoveryBenzamide Class